Drug Approval | March 21, 2022
Glenmark receives ANDA approval for Lacosamide tablets
The company plans to launch the product immediately
The company plans to launch the product immediately
All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform
Moving well beyond the traditional approach of testing a vaccine’s collective response in large populations, this precision approach can identify how an individual’s own immune system responds to a vaccine, offering an unprecedented opportunity to measure vaccine safety and effectiveness
The drug is indicated for use in combination with other drugs
Spread over 43,000 square feet, the facility will be set up to cater to the increasing demand for transformative molecular testing in India and across the world for early and accurate diagnosis
Augnito in association with Japanese company Fujifilm enables voice recognition within their radiology information system platform
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The facility will produce 150 million vaccine doses per year
Inconsistent antibody performance is a significant challenge for researchers and sits at the heart of the reproducibility crisis observed in biomedical research
mRNA-based therapies involve the administration of mRNA in patients so that patients' own cells can produce the encoded therapeutic antibody
Subscribe To Our Newsletter & Stay Updated
